Phenyl Glycolipids with Different Glycosyl Groups Exhibit Marked Differences in Murine and Human iNKT Cell Activation

Glycosphingolipids (GSLs) bearing the agalactosyl headgroup and the acyl chain terminated with a phenyl derivative were found to be more potent than agalactosyl ceramide (alpha GalCer) to stimulate both murine and human invariant natural killer T (iNKT) cells and to induce an antibody isotope switch to IgG. In this study, we replaced the galactosyl group with glucose (alpha Glc) and its fluoro-analogs and found that phenyl GSLs with alpha Glc (C34-Glc) and its fluoro-analog 6F-C34-Glc were stronger than those with alpha Gal in stimulating human iNKT cells but weaker in mice. Their activities have a strong correlation with the binding avidities of the ternary interaction between the iNKT-cell receptor (iNKTCR) and CD1d-GSL complex. It was the iNKTCR rather than CD1d that dictated the species-specific responses. C34-Glc was further used as an adjuvant for a SSEA4-crm-197 vaccine, and after immunization in mice, the vaccine was highly effective against Lewis lung carcinoma.